Biotechnology

Auris Medical Holding AG (NASDAQ: EARS) Q2 2020 earnings call dated Sep. 17, 2020. Corporate Participants: Thomas Meyer -- Chief…

Applied Genetic Technologies Corp.  (NASDAQ: AGTC) Q4 2020 earnings call dated Sep. 09, 2020 Corporate Participants: Sue Washer -- President and Chief…

Ascendis Pharma A/S  (NASDAQ: ASND) Q2 2020 earnings call dated Aug. 27, 2020 Corporate Participants: Scott T. Smith -- Senior Vice President…

Palatin Technologies Inc  (NYSEAMERICAN : PTN) Q4 2020 earnings call dated Sep. 28, 2020 Corporate Participants: Carl Spana -- President and Chief…

https://www.youtube.com/watch?v=WOSh4S0zUds For healthcare systems across the world, currently, the first priority is to find an effective treatment for coronavirus, at…

AnPac Bio-Medical Science Co., Ltd (NASDAQ: ANPC) earnings call dated September 10, 2020 Corporate Participants: Phil Case -- Marketing and Investor Relations…

BeyondSpring Inc. (NASDAQ: BYSI) Q2 2020 earnings call dated Sep. 03, 2020 Corporate Participants: Scott Eckstein -- Vice President Lan Huang -- Co-Founder, Chairman…

Illumina, Inc. (NASDAQ: ILMN), a pioneer in genome sequencing technology, has strived to strengthen its unique position in the healthcare…

Silence Therapeutics PLC (LON: SLN) Q2 2020 earnings call dated Sep. 14, 2020 Corporate Participants: Gem Hopkins -- Head of Investor Relations…

Avid Bioservices, Inc.  (NASDAQ: CDMO) Q1 2021 earnings call dated Sep. 01, 2020 Corporate Participants: Tim Brons -- Investor Relations Nicholas Green -- President…

Aimmune Therapeutics Inc (NASDAQ: AIMT) Q2 2020 earnings call dated July 30, 2020   Corporate Participants: DeDe Sheel -- Vice President of…

So far, COVID-19 has claimed more than 800,000 lives all over the world. The biomedical community is rigorously working on…

In recent times, investors have been betting on the biotech companies that are in the race to develop the COVID-19…

A lot of stocks in the biotech space have skyrocketed this year after their announcements and advances in finding a…

After Novavax (NASDAQ: NVAX) reported its progress on developing the COVID-19 vaccine at the end of February, the shares of…

Aurinia Pharmaceuticals Inc  (NASDAQ: AUPH) Q2 2020 earnings call dated Aug. 11, 2020 Corporate Participants: Glenn Schulman -- Senior Vice President, Corporate…

Sage Therapeutics Inc (NASDAQ: SAGE) Q2 2020 earnings call dated August 10, 2020 Corporate Participants: Jeff Boyle -- Senior Director of Investor…

Novavax Inc  (NASDAQ: NVAX) Q2 2020 earnings call dated Aug. 10, 2020 Corporate Participants: Silvia Taylor -- Senior Vice President, Investor Relations…

Novavax (NASDAQ: NVAX) reported a loss of $17.5 million or $0.30 per share for the second quarter of 2020. Revenue…

Moderna Inc. (NASDAQ: MRNA) Q2 2020 earnings call dated Aug. 05, 2020 Corporate Participants: Lavina Talukdar -- Head of Investor Relations Stephane…

Moderna, Inc., (Nasdaq: MRNA), a prime contender in Covid-19 vaccine research, on Wednesday, reported second-quarter financial results that smashed past…